These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29545376)

  • 1. Penetrating the Barriers to Successful α-Radioimmunotherapy.
    Carlin S
    J Nucl Med; 2018 Jun; 59(6):934-936. PubMed ID: 29545376
    [No Abstract]   [Full Text] [Related]  

  • 2. The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?
    Barbet J; Chatal JF
    Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):271-3. PubMed ID: 21161707
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective alpha-particle-mediated radioimmunotherapy of murine leukemia.
    Huneke RB; Pippin CG; Squire RA; Brechbiel MW; Gansow OA; Strand M
    Cancer Res; 1992 Oct; 52(20):5818-20. PubMed ID: 1394209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
    Ménager J; Gorin JB; Fichou N; Gouard S; Morgenstern A; Bruchertseifer F; Davodeau F; Kraeber-Bodéré F; Chérel M; Gaschet J; Guilloux Y
    Med Sci (Paris); 2016 Apr; 32(4):362-9. PubMed ID: 27137693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can α-radioimmunotherapy increase efficacy for the systemic control of cancer?
    Allen BJ
    Immunotherapy; 2011 Apr; 3(4):455-8. PubMed ID: 21463184
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha particle therapy poised to become new line of cancer treatment.
    Kotz D
    J Nucl Med; 1998 Feb; 39(2):17N-19N, 36N. PubMed ID: 9476918
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with
    Bäck T; Chouin N; Lindegren S; Kahu H; Jensen H; Albertsson P; Palm S
    J Nucl Med; 2017 Apr; 58(4):598-604. PubMed ID: 27688477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Vistas in Alpha Therapy of Infectious Diseases.
    Dadachova E
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S49-S52. PubMed ID: 31427256
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha particles more promising than toxins?
    Barbet J; Chérel M; Chatal JF
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):849-50. PubMed ID: 20306031
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential and pitfalls of therapy with alpha-particles.
    Welch MJ
    J Nucl Med; 2005 Aug; 46(8):1254-5. PubMed ID: 16085579
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha-radioimmunotherapy: a review of recent developments].
    Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
    Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [9th Symposium on Targeted Alpha Therapy].
    Kaku Igaku; 2015 Nov; 52(4):367-8. PubMed ID: 27263271
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis.
    Macklis RM; Lin JY; Beresford B; Atcher RW; Hines JJ; Humm JL
    Radiat Res; 1992 May; 130(2):220-6. PubMed ID: 1574578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors.
    Kodaira S; Li HK; Konishi T; Kitamura H; Kurano M; Hasegawa S
    PLoS One; 2017; 12(6):e0178472. PubMed ID: 28658304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.
    Zalutsky MR
    J Nucl Med; 2006 Aug; 47(8):1238-40. PubMed ID: 16882999
    [No Abstract]   [Full Text] [Related]  

  • 19. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor therapy with targeted atomic nanogenerators.
    McDevitt MR; Ma D; Lai LT; Simon J; Borchardt P; Frank RK; Wu K; Pellegrini V; Curcio MJ; Miederer M; Bander NH; Scheinberg DA
    Science; 2001 Nov; 294(5546):1537-40. PubMed ID: 11711678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.